Metabolic & Endocrine Research
Advancing Diabetes Clinical Research
Diabetes affects millions worldwide and continues to be one of the fastest-growing chronic health conditions. CenExel partners with sponsors to accelerate innovative diabetes treatments through expert-led clinical trials focused on Type 1 Diabetes, Type 2 Diabetes, obesity-related metabolic disorders, and emerging endocrine therapies.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Leading Diabetes & Metabolic Clinical Research
CenExel combines scientific expertise, experienced investigators, and diverse patient populations to support successful diabetes and metabolic clinical trials. Our specialized teams focus on improving patient outcomes while delivering reliable, high-quality data from early-phase studies through post-market research.
Conditions Covered
Diabetes Conditions We Research
Our diabetes and metabolic research programs support a broad range of endocrine and metabolic disorders across adult and pediatric populations.
- Type 1 Diabetes
- Type 2 Diabetes
- Prediabetes
- Obesity & Weight Management
- Insulin Resistance
- Diabetic Neuropathy
- Metabolic Syndrome
- Hyperglycemia
Our Approach
Why Sponsors Choose CenExel for Diabetes Research
CenExel provides specialized metabolic research expertise, rapid patient recruitment, and operational excellence to help sponsors achieve successful clinical outcomes.
01
Metabolic Research Expertise
Our investigators specialize in diabetes, obesity, and endocrine disorders with extensive experience across all trial phases.
02
Diverse Patient Access
We connect sponsors with diverse patient populations to improve enrollment speed and study representation.
03
Advanced Biomarker Support
Our sites support continuous glucose monitoring (CGM), insulin therapy evaluation, and advanced metabolic biomarker analysis.
04
Fast Enrollment Performance
CenExel consistently delivers strong enrollment performance through targeted outreach and experienced recruitment teams.
Phase Coverage
Supported Diabetes Trial Phases
CenExel supports early and late-phase diabetes clinical trials — from first-in-human metabolic studies through Phase IV post-market programs.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Diabetes Task Force
CenExel supports a wide range of diabetes and metabolic clinical trials, including insulin therapies, GLP-1 treatments, obesity management, and cardiovascular-metabolic research.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
